FDA Watchers Divided Between Woodcock, Sharfstein For Agency Chief

By Beth Wang / February 8, 2021 at 8:03 PM

President Joe Biden has yet to name a nominee for FDA commissioner, but policy watchers are making their preferences known, with more than 80 health organizations and advocacy groups backing FDA drug center director Janet Woodcock, who is currently serving as acting FDA chief, and 18 scientists, researchers and policy experts saying they want former FDA Principal Deputy Commissioner Joshua Sharfstein in the role.


Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.